Atlas Trials

Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization

Clinical trial NCT01514617 · UNKNOWN

Trial details

NCT number
NCT01514617
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Leiomyomas
Start date
2012-01-01
Primary completion
2025-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.